External quality assessment (EQA) schemes in clinical chemistry, microbiology, and laboratory haematology have been running for many years on a national basis. They use computerised methods of analysing the results and the statistical methods in these analyses permit confident decisions to be taken on the need for remedial action when a laboratory falls persistently below a predefined standard.
provides automatically calculated scores for the pathologist's performance along with simple statistical evaluation. The scores can be calculated by comparison with the consensus of the group or with correct diagnoses if they are known. A histogram indicating the distribution of performance within the group can be produced. The program can accept uncertainty in the form of differential diagnosis lists from participants. Potentially dangerous diagnostic errors can be identified and handled separately. Participants are identified only by code numbers and confidentiality can easily be enforced. The program is currently being used in the national renal pathology EQA scheme and in the local general histopathology scheme in the East Midlands. Conclusions-This program offers solutions to problems which have bedevilled the organisers of histopathology EQA schemes. It offers confidential advice to pathologists and will help to identify areas where an individual might benefit from continuing career grade medical education. It raises the possibility of the development of nationally agreed standards of performance in the reporting of pathological specimens, and it may be applicable to other specialties where textual reports are produced. (J Clin Pathol 1993; 46:357-363) External quality assessment (EQA) schemes in clinical chemistry, microbiology, and laboratory haematology have been running for many years on a national basis. They use computerised methods of analysing the results and the statistical methods in these analyses permit confident decisions to be taken on the need for remedial action when a laboratory falls persistently below a predefined standard.
The situation in histopathology is radically different. EQA schemes are relatively new. They are usually small and organised locally. The analysis of responses rarely goes beyond a laborious manual tabulation of the numbers of pathologists supporting each of a number of suggested diagnoses for each case. There is usually no further statistical analysis; an assessment of the performance of individual histopathologists is rarely attempted. In the absence of any personal type of report the participant has to assess him or herself in a completely subjective way, often by memory, from diagnoses made months before.
Without any objective assessment it is impossible for criteria of acceptable performance to be developed. Without such criteria the EQA scheme cannot inform a pathologist whether an adequate standard is being maintained.
It could be argued that histopathology EQA schemes assess the performance of individuals, not laboratories, so a comparison with other laboratory disciplines is invalid. The primary purpose of an EQA scheme is to detect when a laboratory is providing a seriously substandard service. In the histopathology laboratory the output depends on many processes, but its essence is the final opinion of the histopathologist. There ferences which are trivial can be recorded in the comments box; they will then be available to the participants but will not be used in the personal analysis. (7) To maintain confidentiality, the correlation between numerical codes and participants' names need only be known by one person. If that person has nothing to do with the rest of the system, he or she can be asked only to put folded papers into appropriate envelopes, and so be kept unaware of the score of any individual pathologist. If a participant falls below acceptable standard (however that may be defined in the future), a "Dear colleague" letter could be sent by a similar procedure along with a breakdown of cases where a low score or a dangerous diagnosis was recorded. This should enable the participant to pinpoint the cause of the poor performance and act accordingly. Histopathology external quality assessment is one form of medical audit and it is clearly the responsibility of the profession as a whole to define acceptable standards of performance. Until now this has been extremely difficult in histopathology but over a period of several EQA circulations using the computerised analysis outlined in this paper it would be possible for bodies such as the Histopathology Quality Assurance Advisory Panel and the Royal College of Pathologists' Histopathology Specialty Advisory Committee to define an agreed minimal level of performance. For individual pathologists over a period of time specific areas of weakness for that particular histopathologist can be identified. This could obviously be very useful in the selection of the most appropriate continuing career grade medical education courses. Procedures will also have to be evolved to deal with the situation where individual pathologists are persistently making serious errors in their histological diagnoses. In assessing satisfactory performance it will probably be necessary to take into account both the overall score and the presence of serious errors; otherwise individual participants could avoid the possibility of making serious errors by the simple technique of giving deliberately vague and strictly neutral diagnoses.
To facilitate comparability on a national basis the National Coordinating Centre is actively considering the possibility of exchanging case material between schemes from diverse parts of the United Kingdom. If each circulation of, say, 15 slides were to include two or three cases which had been used in several other centres then over a period of time it might be possible to define a national standard of satisfactory performance, perhaps as falling no more than two standard deviations below the national mean score. There would obviously be a need for considerable discussion within the profession as to what constitutes a satisfactory level of performance and it is hoped that the suggestions contained in this paper will engender a constructive debate on this very difficult problem.
With adequate safeguards of confidentiality this method of histopathology EQA analysis should not be unduly inquisitorial, particularly if the option to return responses anonymously is maintained. In practice it has been accepted in the National Renal Pathology EQA Scheme and in the local histopathology EQA scheme in the East Midlands. Relatively few anonymous responses are being received.
This program has the endorsement of the Histopathology National EQA Steering Committee for the analysis of general histopathology EQA schemes.
Addendum
Since submission of this paper the program has been developed further. There is now a facility to identify cases as being of a specific type: skin, gynaecological, gastroenterological, etc. A report can then be produced which gives participants a personal breakdown of their mean "score" in each of the subspecialties, along with the mean and standard deviation of the group for comparison. The potential for guiding the use of continuing medical education (CME), and for monitoring its effectiveness, is obvious.
We are grateful for the advice and support of the Histopathology National EQA Steering Committee and many other pathologists. Invaluable statistical advice was provided by Dr Paul Burton. The program uses Omnis 7, a product of Blyth Software. It was developed on computers provided by the Department of Health (for the National Renal Pathology EQA scheme) and from Trent Regional Health Authority Research Committee.
